Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.
Condition: Urothelial Carcinoma Intervention: Drug: Cabozantinib Sponsors: Johannes Gutenberg University Mainz; Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials